Efficacy and Safety of Oxybutynin Chloride Topical Gel for Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled Multicenter Study

Yearbook of Urology ◽

10.1016/s0084-4071(10)79446-x ◽

2010 ◽

Vol 2010 ◽

pp. 36-37

Author(s):

E.S. Rovner

Keyword(s):

Overactive Bladder ◽

Multicenter Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Efficacy and Safety of Oxybutynin Chloride Topical Gel for Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled, Multicenter Study

The Journal of Urology ◽

10.1016/j.juro.2008.11.125 ◽

2009 ◽

Vol 181 (4) ◽

pp. 1764-1772 ◽

Author(s):

David R. Staskin ◽

Roger R. Dmochowski ◽

Peter K. Sand ◽

Scott A. MacDiarmid ◽

Kim E. Caramelli ◽

...

Keyword(s):

Overactive Bladder ◽

Multicenter Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Faculty Opinions recommendation of A randomized double-blind placebo-controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndrome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1090972.544337 ◽

2007 ◽

Author(s):

Rodolfo Testa

Keyword(s):

Overactive Bladder ◽

Multicentre Study ◽

Overactive Bladder Syndrome ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

522 EFFICACY AND SAFETY OF OXYBUTYNIN TOPICAL GEL (84 MG OR 56 MG/DAY) IN PATIENTS WITH URGENCY AND/OR MIXED URINARY INCONTINENCE: RESULTS OF A RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED STUDY

The Journal of Urology ◽

10.1016/j.juro.2012.02.594 ◽

2012 ◽

Vol 187 (4S) ◽

Author(s):

Evan Goldfischer ◽

Peter Sand ◽

Jill Peters-Gee

Keyword(s):

Urinary Incontinence ◽

Mixed Urinary Incontinence ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Efficacy and Safety of OnabotulinumtoxinA for Idiopathic Overactive Bladder: A Double-Blind, Placebo Controlled, Randomized, Dose Ranging Trial

Yearbook of Urology ◽

10.1016/j.yuro.2011.05.045 ◽

2011 ◽

Vol 2011 ◽

pp. 25-26

Author(s):

E.S. Rovner

Keyword(s):

Overactive Bladder ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

40. Long-Term Results of a Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Safety and Potential Activity of Escalating Doses of hMaxi-K Gene Transfer in Female Participants with Overactive Bladder and Detrusor Overactivity

Molecular Therapy ◽

10.1016/s1525-0016(16)35844-0 ◽

2012 ◽

Vol 20 ◽

pp. S16

Keyword(s):

Gene Transfer ◽

Overactive Bladder ◽

Multicenter Study ◽

Detrusor Overactivity ◽

Long Term Results ◽

Double Blind ◽

Double Blind Placebo ◽

Potential Activity

Download Full-text

A double-blind placebo controlled multicenter study to evaluate the efficacy and safety of MBP8298 in subjects with secondary progressive multiple sclerosis (SPMS)

http://isrctn.org/> ◽

10.1186/isrctn98373474 ◽

2013 ◽

Author(s):

Mark Freedman

Keyword(s):

Multiple Sclerosis ◽

Multicenter Study ◽

Progressive Multiple Sclerosis ◽

Secondary Progressive Multiple Sclerosis ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Secondary Progressive

Download Full-text

A double-blind, placebo-controlled, randomized-withdrawal, multicenter study of the efficacy and safety of sodium oxybate in pediatric subjects with narcolepsy with cataplexy

Sleep Medicine ◽

10.1016/j.sleep.2017.11.771 ◽

2017 ◽

Vol 40 ◽

pp. e263

Author(s):

G. Plazzi ◽

C. Ruoff ◽

M. Lecendreux ◽

Y. Dauvilliers ◽

C. Rosen ◽

...

Keyword(s):

Multicenter Study ◽

Sodium Oxybate ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Reply to Christopher C.K. Ho's Letter to the Editor re: David Bar-Or, Kristin M. Salottolo, Alessandro Orlando, James V. Winkler. A Randomized Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of Two Doses of the Tramadol Orally Disintegrating Tablet for the Treatment of Premature Ejaculation Within Less Than 2 Minutes. Eur Urol 2012;61:736–43

European Urology ◽

10.1016/j.eururo.2011.10.008 ◽

2012 ◽

Vol 61 (4) ◽

pp. e25-e26

Author(s):

David Bar-Or ◽

Kristin M. Salottolo

Keyword(s):

Multicenter Study ◽

Premature Ejaculation ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Orally Disintegrating Tablet ◽

Letter To The Editor

Download Full-text

P-288 Global Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Compare Efficacy and Safety of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Plus nab-Paclitaxel and Gemcitabine vs. Placebo Plus nab-Paclitaxel and Gemcitabine

Annals of Oncology ◽

10.1093/annonc/mdw199.278 ◽

2016 ◽

Vol 27 ◽

pp. ii84

Author(s):

Tempero Margaret ◽

Hingorani Sunil ◽

Zheng Lei ◽

Reni Michele ◽

Hendifar Andrew ◽

...

Keyword(s):

Multicenter Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Recombinant Human Hyaluronidase

Download Full-text

Efficacy and Safety of the Selective β3-Adrenoceptor Agonist Mirabegron in Japanese Patients with Overactive Bladder: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study

LUTS Lower Urinary Tract Symptoms ◽

10.1111/luts.12053 ◽

2014 ◽

Vol 7 (2) ◽

pp. 84-92 ◽

Author(s):

Osamu YAMAGUCHI ◽

Eiji MARUI ◽

Yasuhiko IGAWA ◽

Masayuki TAKEDA ◽

Osamu NISHIZAWA ◽

...

Keyword(s):

Overactive Bladder ◽

Japanese Patients ◽

Dose Finding ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Adrenoceptor Agonist ◽

Finding Study ◽

Dose Finding Study

Download Full-text